Philip J Lupo1, Laura E Mitchell, Elizabeth Goldmuntz. 1. Human Genetics Center, Division of Epidemiology, Human Genetics and Environmental Sciences, University of Texas School of Public Health, Houston, TX, USA.
Abstract
BACKGROUND: Although congenital heart defects (CHDs) are a common and serious group of birth defects, relatively little is known about the causes of these conditions, and there are no established prevention strategies. There is, however, evidence suggesting that the risk of CHDs in general, and conotruncal and related defects (CTRDs) in particular, may be associated with maternal folate status and genetic variants of folate-related genes. Although several folate-related genes have been studied as they relate to CHDs and CTRDs (e.g., MTHFR), others have not been adequately assessed. METHODS: Case-parent triads were examined using log-linear analyses to assess the associations between CTRDs and both the genotype inherited by the case and the maternal genotype for the following variants: NAT1 1095C>A, NOS3 894G>T, and TYMS 1494del6. Subgroup analyses were also conducted among cases with classic conotruncal defects and cases with normally related great arteries. RESULTS: The results provided little evidence that CTRD risk was associated with the genotype inherited by the case for any of the analyzed variants. However, our results suggest that CTRD risk may be associated with the maternal genotype for NOS3 894G>T (p = 0.024 in the subgroup with normally related great arteries) and TYMS 1494del6 (p = 0.048 in the subgroup with classic conotruncal defects). However, these results were not significant after correcting for multiple comparisons. CONCLUSION: This study provides further evidence that CTRD risk may be related to variation within folate-pathway genes and suggests that these associations are, at least in part, mediated through the maternal genotype.
BACKGROUND: Although congenital heart defects (CHDs) are a common and serious group of birth defects, relatively little is known about the causes of these conditions, and there are no established prevention strategies. There is, however, evidence suggesting that the risk of CHDs in general, and conotruncal and related defects (CTRDs) in particular, may be associated with maternal folate status and genetic variants of folate-related genes. Although several folate-related genes have been studied as they relate to CHDs and CTRDs (e.g., MTHFR), others have not been adequately assessed. METHODS: Case-parent triads were examined using log-linear analyses to assess the associations between CTRDs and both the genotype inherited by the case and the maternal genotype for the following variants: NAT1 1095C>A, NOS3 894G>T, and TYMS1494del6. Subgroup analyses were also conducted among cases with classic conotruncal defects and cases with normally related great arteries. RESULTS: The results provided little evidence that CTRD risk was associated with the genotype inherited by the case for any of the analyzed variants. However, our results suggest that CTRD risk may be associated with the maternal genotype for NOS3 894G>T (p = 0.024 in the subgroup with normally related great arteries) and TYMS1494del6 (p = 0.048 in the subgroup with classic conotruncal defects). However, these results were not significant after correcting for multiple comparisons. CONCLUSION: This study provides further evidence that CTRD risk may be related to variation within folate-pathway genes and suggests that these associations are, at least in part, mediated through the maternal genotype.
Authors: Lorenzo D Botto; Angela E Lin; Tiffany Riehle-Colarusso; Sadia Malik; Adolfo Correa Journal: Birth Defects Res A Clin Mol Teratol Date: 2007-10
Authors: Karen S Brown; Leo A J Kluijtmans; Ian S Young; Jayne Woodside; John W G Yarnell; Dorothy McMaster; Liam Murray; Alun E Evans; Colin A Boreham; Helene McNulty; J J Strain; Laura E Mitchell; Alexander S Whitehead Journal: Arterioscler Thromb Vasc Biol Date: 2003-04-10 Impact factor: 8.311
Authors: Ingrid M van Beynum; Christiaan Mooij; Livia Kapusta; Sandra Heil; Martin den Heijer; Henk J Blom Journal: Clin Chem Lab Med Date: 2008 Impact factor: 3.694
Authors: Kelly A Volcik; Gary M Shaw; Huiping Zhu; Edward J Lammer; Cecile Laurent; Richard H Finnell Journal: Birth Defects Res A Clin Mol Teratol Date: 2003-11
Authors: Huiping Zhu; Wei Yang; Nathan Shaw; Spencer Perloff; Suzan L Carmichael; Richard H Finnell; Gary M Shaw; Edward J Lammer Journal: Am J Med Genet A Date: 2012-08-07 Impact factor: 2.802
Authors: Philip J Lupo; Darryl Nousome; Kala Y Kamdar; M Fatih Okcu; Michael E Scheurer Journal: Cancer Causes Control Date: 2012-09-01 Impact factor: 2.506
Authors: Xiang-Yang Lou; Ting-Ting Hou; Shou-Ye Liu; Hai-Ming Xu; Feng Lin; Xinyu Tang; Stewart L MacLeod; Mario A Cleves; Charlotte A Hobbs Journal: Genet Epidemiol Date: 2020-09-30 Impact factor: 2.344
Authors: A J Agopian; Laura E Mitchell; Joseph Glessner; Angela D Bhalla; Anshuman Sewda; Hakon Hakonarson; Elizabeth Goldmuntz Journal: PLoS One Date: 2014-05-06 Impact factor: 3.240